<DOC>
	<DOCNO>NCT00763659</DOCNO>
	<brief_summary>The primary objective LUTEGA determine long term effect ( 1 year ) supplementation fix combination lutein/zeaxanthin omega-3- fatty acid optical density ( OD ) macular pigment patient non- exudative age relate maculopathy . Furthermore , examine whether change optical density different dosage dependent . Possible change lipofuscin content effect drusen AMD patient study . The measurement optical density macular pigment use 1- wavelength reflection method record reflection image 460 nm fundus camera . The patient investigate baseline follow one year four visit . In addition OD- measurement examination include standardized visual acuity test ( ETDRS ) , amsler- grid , slit lamp biomicroscopy , fundus photography ( color autofluorescence ) blood sample .</brief_summary>
	<brief_title>Long Term Effects Lutein/Zeaxanthin Omega-3- Supplementation Optical Density AMD Patients ( LUTEGA )</brief_title>
	<detailed_description />
	<criteria>All non exudative form age relate maculopathy Exudative age relate maculopathy</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>